Efficacy of Botox versus Placebo for Treatment of Patients with Major Depression
Iran J Public Health
2016
Abbas ZAMANIAN, Atefeh GHANBARI JOLFAEI, Golnaz MEHRAN, Zahra AZIZIAN
Facing depression with botulinum toxin: A randomized controlled trial
Journal of Psychiatric Research
2012
M. Axel Wollmer, Claas de Boer , Nadeem Kalak , Johannes Beck , Thomas Götz , Tina Schmidt ,Muris Hodzic, Ursula Bayer, Thilo Kollmann , Katja Kollewe , Daniela Sönmez , Katja Duntsch, Martin D. Haug, Manfred Schedlowski, Martin Hatzinger, Dirk Dressler, Serge Brand, Edith Holsboer-Trachsler, Tillmann H.C. Kruger
The safety and efficacy of botulinum toxin A on the treatment of depression
Brain and Behavior
2021
Qilin Zhang, Wenqi Wu, Yuxin Fan, Yang Li, Jing Liu, Yingying Xu, Caixia Jiang, Zhen Tang, Cong Cao, Tong Liu, Li-Hua Chen,Hua Hu, Weifeng Luo
Effects of botulinum toxin type a on mood and cognitive function in patients with parkinson’s disease and depression
Am J Transl Res
2021
Changzheng Zhu, Kuijie Wang, Ting Yu, Huaqing
OnabotulinumtoxinA for the treatment of major depressive disorder: a phase 2 randomized, double-blind, placebo- controlled trial in adult females
International Clinical Psychopharmacology
2019
Mitchell F. Brina,b, Suresh Durgamc, Arlene Luma, Lynn Jamesa, Jeen Liua, Michael E. Thased and Armin Szegedie
Treatment of Major Depressive Disorder Using Botulinum Toxin A: A 24-Week Randomized, Double-Blind, Placebo-Controlled Study
j Clin Psychiatry
2014
Michelle Magid, MD; Jason S. Reichenberg, MD; Poppy E. Poth, BS; Henry T. Robertson, PhD; Amanda K. LaViolette, MD, MPH; Tillmann H. C. Kruger, MD; and M. Axel Wollmer, MD
Treatment of depression with onabotulinumtoxinA: A randomized, double-blind, placebo controlled trial
Journal of Psychiatric Research
2013
Eric Finzi, Norman E. Rosenthal
Treatment of Depression with Botulinum Toxin A: A Case Series
Dermatological Surgery
2006
Eric Finzi, M.D. PhD
Erika Wasserman, PhD